Skip UCSF navigation|About accessibility UCSF University of California, San Francisco
About UCSF
Search UCSF
UCSF Medical Center
End of UCSF navigation
Skip breadcrumbs navigationUCSF which contains School of Pharmacy which contains News Archive which contains Soller Comments on Acetaminophen
School of Pharmacy•
News Archive

End of section-level navigation

News Archive

Soller Comments on Acetaminophen

Tuesday, July 7, 2009

Acetaminophen William Soller, PhD, UCSF faculty member and expert on food and drug law and regulations comments on the June 30, 2009 vote of a US Food and Drug Administration (FDA) advisory committee to lower the US maximum over-the-counter dose of acetaminophen and make the current maximum single dose of the drug be available by prescription only. Soller's research on acetaminophen was included as part of the advisory committee's deliberations.

Full Story:

FDA Crackdown on Acetaminophen

UCSF Clinical Pharmacy Study Is Part of FDA Acetaminophen Deliberations

More:

FDA Advises Lower Dosage for Popular Painkiller

June 29-30, 2009: Joint Meeting of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Life Support Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee Meeting Announcement

Acetaminophen and Liver Injury: Q and A for Consumers

Go To: UCSF School of Pharmacy News

Other News